JiangSu WuZhong Pharmaceutical Development Co., Ltd.

Equities

600200

CNE000000YP4

Pharmaceuticals

End-of-day quote Shanghai S.E. 06:00:00 2024-04-28 pm EDT 5-day change 1st Jan Change
10.95 CNY +3.79% Intraday chart for JiangSu WuZhong Pharmaceutical Development Co., Ltd. -1.35% +33.21%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
JiangSu WuZhong Pharmaceutical Development Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
JiangSu WuZhong Pharmaceutical Development Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
JiangSu WuZhong Pharmaceutical Development Co., Ltd. cancelled the transaction announced on April 25, 2023 CI
JiangSu WuZhong Pharmaceutical Development Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Jiangsu WuZhong Pharma to Invest 30 Million Yuan in Local Biotech Firm MT
Wuzhong Pharmaceutical Development's Unit Gets Registration Certificate for Linezolid Sodium Chloride Injection MT
JiangSu WuZhong Pharmaceutical Development Co., Ltd.(XSSC:600200) added to S&P Global BMI Index CI
JiangSu WuZhong Pharmaceutical Development Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
JiangSu WuZhong Pharmaceutical Development Co., Ltd. cancelled the transaction announced on November 11, 2021 CI
JiangSu WuZhong Pharmaceutical Development Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
JiangSu WuZhong Pharmaceutical Development Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
JiangSu WuZhong Pharmaceutical Development Co., Ltd. announced that it expects to receive CNY 1.2 billion in funding from Zhejiang Fuji Holdings Group Co., Ltd. and other investors CI
Cinkate Medicine Chemical Intermediate Co., Ltd. agreed to acquire 15% stake in Suzhou Changzheng Cinkate Pharmaceutical Co., Ltd. from JiangSu WuZhong Pharmaceutical Development Co., Ltd. for CNY 33 million. CI
JiangSu WuZhong Pharmaceutical Development Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
JiangSu WuZhong Pharmaceutical Development Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
JiangSu WuZhong Pharmaceutical Development Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
JiangSu WuZhong Pharmaceutical Development Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
JiangSu WuZhong Pharmaceutical Development Co., Ltd. cancelled the transaction to acquire 70% stake in Shanghai Weina Cosmetics Co., Ltd., from Weina Hongkong Co., Limited. CI
Jiangsu Wuzhong Pharmaceutical Group Corporation announced that it expects to receive CNY 340 million in funding from JiangSu WuZhong Pharmaceutical Development Co., Ltd. CI
JiangSu WuZhong Pharmaceutical Development Co., Ltd. announced that it expects to receive CNY 300 million in funding from Suzhou Fuji Suwu Pharmaceutical Technology Partnership Enterprise (Limited Partnership) CI
JiangSu WuZhong Pharmaceutical Development Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
JiangSu WuZhong Pharmaceutical Development Co., Ltd. agreed to acquire 70% stake in Shanghai Weina Cosmetics Co., Ltd., from Weina Hongkong Co., Limited. CI
Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Jiangsu Wuzhong Industrial Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2020 CI
Chart JiangSu WuZhong Pharmaceutical Development Co., Ltd.
More charts
JiangSu WuZhong Pharmaceutical Development Co Ltd, formerly Jiangsu Wuzhong Industrial Co Ltd, is a China-based company mainly engaged in pharmaceutical business. The Company's business includes pharmaceuticals, chemicals and real estate. Pharmaceutical business mainly involves pharmaceutical research, development, manufacture and sales. Chemical business mainly includes research, development, manufacture and sales of organic pigments, dyes and intermediates. Its main production varieties are used to produce reactive dyes and organic pigments. Real estate business includes commercial housing and affordable housing.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
10.95 CNY
Average target price
12.7 CNY
Spread / Average Target
+15.98%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 600200 Stock
  4. News JiangSu WuZhong Pharmaceutical Development Co., Ltd.
  5. Wuzhong Pharmaceutical Development's Unit Gets Registration Certificate for Linezolid Sodium Chloride Injection